Pallas Capital Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$337K Sell
5,372
-1,683
-24% -$117K 0.01% 612
2025
Q4
$468K Buy
7,055
+2,757
+64% +$178K 0.02% 551
2025
Q3
$289K Sell
4,298
-2,074
-33% -$164K 0.01% 679
2025
Q2
$556K Buy
6,372
+300
+5% +$23.5K 0.02% 473
2025
Q1
$415K Buy
6,072
+2,571
+73% +$210K 0.02% 522
2024
Q4
$272K Buy
+3,501
New +$259K 0.01% 488
2024
Q3
Sell
-5,179
Closed -$573K 611
2024
Q2
$573K Buy
5,179
+45
+0.9% +$5.69K 0.03% 292
2024
Q1
$712K Buy
5,134
+83
+2% +$10.4K 0.03% 237
2023
Q4
$627K Sell
5,051
-25
-0.5% -$2.55K 0.03% 242
2023
Q3
$431K Buy
5,076
+15
+0.3% +$1.69K 0.03% 249
2023
Q2
$696K Buy
5,061
+819
+19% +$99.1K 0.03% 175
2023
Q1
$525K Buy
4,242
+166
+4% +$18.6K 0.05% 180
2022
Q4
$440K Buy
4,076
+12
+0.3% +$1.32K 0.04% 193
2022
Q3
$458K Sell
4,064
-3
-0.1% -$254 0.05% 172
2022
Q2
$341K Sell
4,067
-853
-17% -$77.8K 0.05% 173
2022
Q1
$605K Sell
4,920
-1,232
-20% -$135K 0.08% 144
2021
Q4
$649K Sell
6,152
-212
-3% -$30.5K 0.08% 163
2021
Q3
$986K Buy
6,364
+116
+2% +$14.6K 0.11% 148
2021
Q2
$804K Buy
6,248
+1,788
+40% +$172K 0.11% 139
2021
Q1
$382K Buy
+4,460
New +$419K 0.09% 140

Other funds holding DXCM

Pallas Capital Advisors's DXCM Position: Q1 2026 in Review

Pallas Capital Advisors reduced its DexCom (DXCM) stake by 24% in Q1 2026, selling an estimated $117K and leaving 5,372 shares worth $337K. The position accounts for 0.01% of the portfolio, ranked #612.

Pallas Capital Advisors first reported a position in DXCM in Q1 2021 and has held it in 20 quarters since. The position peaked at $986K in Q3 2021. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Pallas Capital Advisors held 5,372 shares of DexCom worth $337K as of Q1 2026.
  • Pallas Capital Advisors sold 1,683 DexCom shares in Q1 2026, an estimated $117K.
  • DexCom made up 0.01% of Pallas Capital Advisors's portfolio in Q1 2026, its #612 holding.
  • Pallas Capital Advisors first reported a position in DexCom in Q1 2021 and has held it in 20 quarters since.
  • Pallas Capital Advisors's DexCom position peaked at $986K in Q3 2021.
  • 957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Pallas Capital Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.